Naloxone buccal (Taho Pharma)

N/A

Report date: 2023/09/06 17:58:20

Base Information

Drug NameNaloxone buccal (Taho Pharma)
Drug Alias NameNaloxone buccal film (Taho Pharma)TAH-2231
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOpioid receptors antagonists
TargetsOpioid receptors
Therapy Area/IndicationsOpioid-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTAHO Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTAHO Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsOpioid-Related Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A